Drug record
What four public record sets show for warfarin. Saved Nov 10, 2026.
| Shortage | Not on the FDA shortage list | Details |
|---|---|---|
| Pharmacy cost | $0.088 each for the lowest-cost generic | Details |
| Medicare Part D, 2024 | $46.9 million | Details |
| FDA recall records | 9 | Details |
Whether the FDA lists this drug as in short supply.
The list changes daily, and it covers the national supply. A pharmacy near you can be out of a drug that is not listed, or have one that is. See today's status.
The national average price retail pharmacies pay to buy it (NADAC).
The lowest-cost generic on file is Jantoven 7.5 Mg Tablet: pharmacies pay about $0.088 each, or $2.63 for 30.
| Product as surveyed | Type | Pharmacy pays | For 30 | Price since |
|---|---|---|---|---|
| JANTOVEN 1 MG TABLET | Generic | $0.102 per each | $3.07 | Oct 21, 2026 |
| JANTOVEN 10 MG TABLET | Generic | $0.109 per each | $3.27 | Oct 21, 2026 |
| JANTOVEN 2 MG TABLET | Generic | $0.095 per each | $2.86 | Oct 21, 2026 |
| JANTOVEN 2.5 MG TABLET | Generic | $0.097 per each | $2.90 | Oct 21, 2026 |
| JANTOVEN 3 MG TABLET | Generic | $0.101 per each | $3.02 | Oct 21, 2026 |
| JANTOVEN 4 MG TABLET | Generic | $0.101 per each | $3.02 | Oct 21, 2026 |
| JANTOVEN 5 MG TABLET | Generic | $0.089 per each | $2.67 | Oct 21, 2026 |
| JANTOVEN 6 MG TABLET | Generic | $0.095 per each | $2.86 | Oct 21, 2026 |
| JANTOVEN 7.5 MG TABLET | Generic | $0.088 per each | $2.63 | Oct 21, 2026 |
| WARFARIN SODIUM 1 MG TABLET | Generic | $0.102 per each | $3.07 | Oct 21, 2026 |
| WARFARIN SODIUM 10 MG TABLET | Generic | $0.109 per each | $3.27 | Oct 21, 2026 |
| WARFARIN SODIUM 2 MG TABLET | Generic | $0.095 per each | $2.86 | Oct 21, 2026 |
| WARFARIN SODIUM 2.5 MG TABLET | Generic | $0.097 per each | $2.90 | Oct 21, 2026 |
| WARFARIN SODIUM 3 MG TABLET | Generic | $0.101 per each | $3.02 | Oct 21, 2026 |
| WARFARIN SODIUM 4 MG TABLET | Generic | $0.101 per each | $3.02 | Oct 21, 2026 |
| WARFARIN SODIUM 5 MG TABLET | Generic | $0.089 per each | $2.67 | Oct 21, 2026 |
| WARFARIN SODIUM 6 MG TABLET | Generic | $0.095 per each | $2.86 | Oct 21, 2026 |
| WARFARIN SODIUM 7.5 MG TABLET | Generic | $0.088 per each | $2.63 | Oct 21, 2026 |
This is not your price. NADAC is the national average that retail pharmacies pay to buy the drug, from the Medicaid survey for the week of Nov 11, 2026. What you pay adds the pharmacy's markup and dispensing fee and depends on your insurance or any discount card. "For 30" is shown only for products priced per tablet or capsule. Brand prices here are before any rebates.
Medicare Part D spending by product, from the latest annual file (2024).
In 2024, Medicare Part D plans and their members paid $46.9 million for the 2 products below. That is down 60% from $116.6 million in 2020.
| Product | 2024 spending | People | Per prescription | Per person, year | 2020 spending |
|---|---|---|---|---|---|
| Warfarin Sodium Warfarin Sodium | $43.7 million | 854,358 | $9.37 | $51.18 | $109.2 million |
| Jantoven Warfarin Sodium | $3.2 million | 82,609 | $8.57 | $38.29 | $7.3 million |
Spending is the gross amount paid at the pharmacy by Part D plans and patients, before manufacturer rebates, which can be large for brand drugs. The same person can use more than one product, so people are not added up across rows. A dash means the file suppresses a small number or has no figure for that year.
Recalls reported to the FDA that name this drug.
The FDA has 9 recall records that name warfarin in the product description (2 Class I · 6 Class II · 1 Class III).
Warfarin Sodium Tablets, USP, 5 mg, 100 Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054. NDC: 0093-1721-01
Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Warfarin Sodium Tablets, USP, 2.5 mg, 100 Tablets per bottle, Rx only, Manufactured For: Teva Pharmaceuticals, Parsippany, NJ 07054. NDC: 0093-1714-01
Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Warfarin Sodium Tablets, USP 1 mg, 100-count bottle, Rx Only, Distributed by: Rising Health, LLC, Saddle Brook, NJ 07663, NDC# 57237-119-01
Reason: Failed Impurities/Degradation Specifications
Warfarin 2.5 ng Lactose Free Caps, Health Innov Pharmacy, 295 Pinehurst Ave, Southern Pines, NC 28387, (910) 246-5155
Reason: Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.
COUMADIN FOR INJECTION (Warfarin Sodium for Injection, USP 5 mg Single-Use Vial Rx Only Distributed by Bristol Meyers Squibb Company, Princeton, NJ 08543 USA NDC 0590-0324-96
Reason: Presence of Particulate Matter: particulate matter identified as metallic-like and non-metallic cellulose fiber particles found in retain vials
Warfarin Sodium Tablets, USP Crystalline, 2 mg, 100 and 1000 Tablet Bottles, Rx Only. Mfd. by: Taro Pharmaceutical Industries, Ltd., Haifa Bay, Israel 26110. Dist. by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532. 100 Tablet Bottle NDC: 51672-4028-1, 1000 Tablet Bottle NDC: 51672-4028-3.
Reason: Failed Content Uniformity Specifications.
WARFARIN SODIUM Tablet, 0.5 mg (1/2 of 1 mg), Rx only, Distributed by: AidaPak Service, LLC, NDC 51672402701
Reason: Labeling: Label Mixup; WARFARIN SODIUM Tablet, 0.5 mg (1/2 of 1 mg) may be potentially mislabeled as SODIUM CHLORIDE, Tablet, 1 mg, NDC 00223176001, Pedigree: AD70636_1, EXP: 5/29/2014.
WARFARIN SODIUM Tablet, 0.5 mg (1/2 of 1 mg), Rx only, Distributed by: AidaPak Service, LLC, NDC 51672402701
Reason: Labeling: Label Mixup; WARFARIN SODIUM, Tablet, 0.5 mg (1/2 of 1 mg) may be potentially mislabeled as SODIUM CHLORIDE, Tablet, 1 mg, NDC 00223176001, Pedigree: AD70636_1, EXP: 5/29/2014.
Warfarin Sodium Tablets, USP 2 mg, Rx Only, 1000 Tablets per bottle, Manufactured by: Cadila Healthcare Ltd Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc., Pennington, NJ 08534, NDC 68382-053-10
Reason: Failed Tablet/Capsule Specifications: A product complaint was received from a pharmacist who discovered that 3 tablets in a 1000-count bottle were oversized.
A recall covers specific lots from one company, not every bottle of the drug. Records include combination products and compounded versions that name this ingredient. Class I is the most serious: use could cause serious harm. Class II may cause temporary or reversible harm. Class III is unlikely to cause harm. To check a bottle, match the lot number on the label. See the live list. Do not stop a medicine because of a recall without asking your pharmacist.
These are saved records as of Nov 10, 2026; the sources update daily to yearly. For current figures open the live report for warfarin. This page is public-record information, not medical advice.